This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Chemicals, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Teruo Ito: Innovator in Pharmaceutical Preparations
Introduction
Teruo Ito is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormone preparations. His innovative work has led to advancements that benefit the medical community and patients alike.
Latest Patents
One of Teruo Ito's key patents is a pharmaceutical preparation containing human growth hormone. This stable preparation involves a molecular weight of about 20,000, or a derivative thereof. The formulation includes a water-soluble heterocyclic compound, such as creatinine, a salt of acetyltryptophane, and nicotinamide. These components work together to prevent the insolubilization of human growth hormone in an aqueous solution. This patent showcases his expertise in creating effective pharmaceutical solutions.
Career Highlights
Teruo Ito is associated with Mitsui Chemicals, Inc., where he has been able to apply his knowledge and skills in the pharmaceutical industry. His work has not only contributed to the company's success but has also had a lasting impact on the field of medicine. With 1 patent to his name, he continues to be a valuable asset in the realm of pharmaceutical innovations.
Collaborations
Throughout his career, Teruo Ito has collaborated with esteemed colleagues such as Akira Fukuhara and Tsutomu Sato. These partnerships have fostered an environment of innovation and have led to the development of groundbreaking pharmaceutical solutions.
Conclusion
Teruo Ito's contributions to the pharmaceutical industry exemplify the importance of innovation in medicine. His work on human growth hormone preparations highlights his commitment to improving healthcare outcomes. As he continues to advance his research, the impact of his inventions will undoubtedly resonate within the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile